Annual SGA
$11.21 M
+$3.61 M+47.44%
December 1, 2023
Summary
- As of February 7, 2025, ZVSA annual SGA is $11.21 million, with the most recent change of +$3.61 million (+47.44%) on December 1, 2023.
- During the last 3 years, ZVSA annual SGA has risen by +$5.85 million (+109.04%).
- ZVSA annual SGA is now at all-time high.
Performance
ZVSA SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$1.83 M
-$211.30 K-10.33%
September 1, 2024
Summary
- As of February 7, 2025, ZVSA quarterly SGA is $1.83 million, with the most recent change of -$211.30 thousand (-10.33%) on September 1, 2024.
- Over the past year, ZVSA quarterly SGA has dropped by -$480.10 thousand (-20.75%).
- ZVSA quarterly SGA is now -53.33% below its all-time high of $3.93 million, reached on June 30, 2023.
Performance
ZVSA Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$429.29 M
-$21.33 M-5.23%
September 1, 2024
Summary
- As of February 7, 2025, ZVSA TTM SGA is -$429.29 million, with the most recent change of -$21.33 million (-5.23%) on September 1, 2024.
- Over the past year, ZVSA TTM SGA has dropped by -$439.28 million (-4396.85%).
- ZVSA TTM SGA is now -711.55% below its all-time high of -$52.90 million.
Performance
ZVSA TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ZVSA Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +47.4% | -20.8% | -4396.9% |
| 3 y3 years | +109.0% | +57.5% | -6897.3% |
| 5 y5 years | +109.0% | +57.5% | -6897.3% |
ZVSA Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +101.0% | -53.3% | +72.8% | -711.5% | at low |
| 5 y | 5-year | at high | +109.0% | -53.3% | +72.8% | -711.5% | at low |
| alltime | all time | at high | +109.0% | -53.3% | +72.8% | -711.5% | at low |
ZyVersa Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.83 M(-10.3%) | $7.71 M(-4.9%) |
| Jun 2024 | - | $2.04 M(-11.6%) | $8.11 M(-18.9%) |
| Mar 2024 | - | $2.31 M(+52.3%) | $9.99 M(-10.9%) |
| Dec 2023 | $11.21 M(+47.4%) | $1.52 M(-31.8%) | $11.21 M(-12.2%) |
| Sep 2023 | - | $2.23 M(-43.3%) | $12.77 M(+10.1%) |
| Jun 2023 | - | $3.93 M(+11.1%) | $11.61 M(+31.3%) |
| Mar 2023 | - | $3.54 M(+14.9%) | $8.84 M(+16.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $7.61 M(+36.3%) | $3.08 M(+190.2%) | $7.61 M(+34.2%) |
| Sep 2022 | - | $1.06 M(-8.8%) | $5.67 M(-10.2%) |
| Jun 2022 | - | $1.16 M(-49.4%) | $6.32 M(+22.6%) |
| Mar 2022 | - | $2.30 M(+101.4%) | $5.15 M(+80.7%) |
| Dec 2021 | $5.58 M(+4.0%) | - | - |
| Dec 2021 | - | $1.14 M(-33.1%) | $2.85 M(+66.9%) |
| Sep 2021 | - | $1.71 M | $1.71 M |
| Dec 2020 | $5.36 M | - | - |
FAQ
- What is ZyVersa Therapeutics annual SGA?
- What is the all time high annual SGA for ZyVersa Therapeutics?
- What is ZyVersa Therapeutics annual SGA year-on-year change?
- What is ZyVersa Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for ZyVersa Therapeutics?
- What is ZyVersa Therapeutics quarterly SGA year-on-year change?
- What is ZyVersa Therapeutics TTM SGA?
- What is the all time high TTM SGA for ZyVersa Therapeutics?
- What is ZyVersa Therapeutics TTM SGA year-on-year change?
What is ZyVersa Therapeutics annual SGA?
The current annual SGA of ZVSA is $11.21 M
What is the all time high annual SGA for ZyVersa Therapeutics?
ZyVersa Therapeutics all-time high annual SGA is $11.21 M
What is ZyVersa Therapeutics annual SGA year-on-year change?
Over the past year, ZVSA annual SGA has changed by +$3.61 M (+47.44%)
What is ZyVersa Therapeutics quarterly SGA?
The current quarterly SGA of ZVSA is $1.83 M
What is the all time high quarterly SGA for ZyVersa Therapeutics?
ZyVersa Therapeutics all-time high quarterly SGA is $3.93 M
What is ZyVersa Therapeutics quarterly SGA year-on-year change?
Over the past year, ZVSA quarterly SGA has changed by -$480.10 K (-20.75%)
What is ZyVersa Therapeutics TTM SGA?
The current TTM SGA of ZVSA is -$429.29 M
What is the all time high TTM SGA for ZyVersa Therapeutics?
ZyVersa Therapeutics all-time high TTM SGA is -$52.90 M
What is ZyVersa Therapeutics TTM SGA year-on-year change?
Over the past year, ZVSA TTM SGA has changed by -$439.28 M (-4396.85%)